Susanne Graef
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susanne Graef has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Fabian Klostermann
Department of Neurology, Charité, Campus Benjamin Franklin Berlin, Germany
1 shared publicationFrank Marzinzik
Department of Neurology, Charité, Campus Benjamin Franklin Berlin, Germany
1 shared publicationGuido Biele
Max Planck Institute for Human Development Berlin, Germany
1 shared publication- Hauke R. Heekeren
Department of Education and Psychology, Freie Universität Berlin, 14195 Berlin, Germany
1 shared publication Johann Wotka
Department of Neurology, Charité, Campus Benjamin Franklin Berlin, Germany
1 shared publicationLea K. Krugel
Max Planck Institute for Human Development Berlin, Germany
1 shared publication
Latest Publications
- 8 January 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 215 (2) , 205-229
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings
The cholinergic system has long been linked to cognitive processes. Two main classes of acetylcholine (ACh) receptors exist in the human brain, namely muscarinic and nicotinic receptors, of which several subtypes occur.
- 8 January 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 215 (2) , 205-229
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings
The cholinergic system has long been linked to cognitive processes. Two main classes of acetylcholine (ACh) receptors exist in the human brain, namely muscarinic and nicotinic receptors, of which several subtypes occur.
- Open Access
- 1 January 2010
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 4, 1811
Differential Influence of Levodopa on Reward-Based Learning in Parkinson's Disease
The mesocorticolimbic dopamine (DA) system linking the dopaminergic midbrain to the prefrontal cortex and subcortical striatum has been shown to be sensitive to reinforcement in animals and humans. Within this system, coexistent segregated striato-frontal circuits have been linked to different functions. In the present study, we tested patients with Parkinson’s disease (PD), a neurodegenerative disorder characterised by dopaminergic cell loss, on two reward-based learning tasks assumed to differentially involve dorsal and ventral striato-frontal circuits. 15 non-depressed and non-demented PD patients on levodopa monotherapy were tested both on and off medication. Levodopa had beneficial effects on the performance on an instrumental learning task with constant stimulus-reward associations, hypothesized to rely on dorsal striato-frontal circuits. In contrast, performance on a reversal learning task with changing reward contingencies, relying on ventral striato-frontal structures, was better in the unmedicated state. These results are in line with the “overdose hypothesis” which assumes detrimental effects of dopaminergic medication on functions relying upon less affected regions in PD. This study demonstrates, in a within-subject design, a double dissociation of dopaminergic medication and performance on two reward-based learning tasks differing in regard to whether reward contingencies are constant or dynamic. There was no evidence for a dose effect of levodopa on reward-based behaviour with the patients’ actual levodopa dose being uncorrelated to their performance on the reward-based learning tasks.
- 1 January 2010
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 4, 1811
Open AccessDifferential Influence of Levodopa on Reward-Based Learning in Parkinson's Disease
The mesocorticolimbic dopamine (DA) system linking the dopaminergic midbrain to the prefrontal cortex and subcortical striatum has been shown to be sensitive to reinforcement in animals and humans. Within this system, coexistent segregated striato-frontal circuits have been linked to different functions. In the present study, we tested patients with Parkinson’s disease (PD), a neurodegenerative disorder characterised by dopaminergic cell loss, on two reward-based learning tasks assumed to differentially involve dorsal and ventral striato-frontal circuits. 15 non-depressed and non-demented PD patients on levodopa monotherapy were tested both on and off medication. Levodopa had beneficial effects on the performance on an instrumental learning task with constant stimulus-reward associations, hypothesized to rely on dorsal striato-frontal circuits. In contrast, performance on a reversal learning task with changing reward contingencies, relying on ventral striato-frontal structures, was better in the unmedicated state. These results are in line with the “overdose hypothesis” which assumes detrimental effects of dopaminergic medication on functions relying upon less affected regions in PD. This study demonstrates, in a within-subject design, a double dissociation of dopaminergic medication and performance on two reward-based learning tasks differing in regard to whether reward contingencies are constant or dynamic. There was no evidence for a dose effect of levodopa on reward-based behaviour with the patients’ actual levodopa dose being uncorrelated to their performance on the reward-based learning tasks.